EIM
MYOK

Essex Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Essex Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,114
Closed -$933K – 440
2018
Q1 		$933K Sell
19,114
-2,391
-11% -$124K 0.12% 220
2017
Q4 		$905K Sell
21,505
-8,393
-28% -$323K 0.12% 221
2017
Q3 		$1.28M Sell
29,898
-18,102
-38% -$578K 0.17% 182
2017
Q2 		$629K Buy
+48,000
New +$632K 0.09% 240

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Essex Investment Management's MYOK Position: Q2 2018 in Review

Essex Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2018, closing a stake of 19,114 shares — an estimated $933K sold.

Essex Investment Management first reported a position in MYOK in Q2 2017 and held it in 4 quarters. The position peaked at $1.28M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q2 2018.

  • Essex Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Essex Investment Management sold 19,114 MyoKardia, Inc. Common Stock shares in Q2 2018, an estimated $933K.
  • Essex Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • Essex Investment Management's MyoKardia, Inc. Common Stock position peaked at $1.28M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2018.

Based on Essex Investment Management's 13F filing for Q2 2018, filed 17 Jul 2018.